NewsBenzingaGuggenheim maintient son conseil d'achat sur Regeneron Pharmaceuticals et relève son objectif de cours à 1100 $ Guggenheim maintient son conseil d'achat sur Regeneron Pharmaceuticals et relève son objectif de cours à 1100 $ Benzinga 2026.11.02 14:21 (GMT+0) Open on Benzinga Other news How to Play AAPL Stock as Apple Acquires an Agentic AI Startup Goldman Sachs Restricts Traders and Bankers From Using Certain Advanced AI Tools HSBC to Set Up Global AI Research Institute in Hong Kong, Initially Focusing on Blockchain Technology and Post-Quantum Cryptography Uber Technologies Stock Outlook: Is Wall Street Bullish or Bearish? Securitize Expands Tokenized US Stocks to 25, Adding 13 Companies Including ExxonMobil and GameStop 3 Cash Cow Stocks I Like Better Than Anthropic Heading into a Historic IPO
HSBC to Set Up Global AI Research Institute in Hong Kong, Initially Focusing on Blockchain Technology and Post-Quantum Cryptography
